NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/19/2025
Back to search
Official data from USPTO
ORBIS BIOSCIENCES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ORBIS BIOSCIENCES
ST13
US500000086382988Class
40, 42
Filing
86382988
Registration
4869227
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
08/12/2025
Trademark type
Word
Nice classes
40, 42
Filing date
09/02/2014
Registration date
12/15/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/19/2025
Last transaction
08/12/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
09/04/2008
First use in commerce
09/04/2008
Drawing code
4
Owner type
03
Owner location
Philadelphia, PA
Examiner
JOHNSON, DONALD
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Adare Pharmaceuticals USA, Inc.
Orbis Biosciences, Inc.
Representatives
C. Blair Barbieri HOVEY WILLIAMS LLP
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Manufacturing services for others in the area of pharmaceutical drug delivery systemsincluding continuous releasepulsatile releaseextended releasesustained releasetaste masked releasedelayed release systemsclinical manufacturing of drug formulations for others to support clinical trialsfabrication and preparation of active pharmaceutical ingredients for otherstechnology scale-up services for othersintegration of technology into manufacturing processes for othersall relating to multiple drug product formatssemi-solidssolutionssuspensionsparticulatessolid dispersionssolid solutions and injectables
Class 42
Pharmaceutical drug delivery technology development services; pharmaceutical drug delivery technology development servicesresearch and development in the area of pharmaceutical drug delivery systemsincluding continuous releasepulsatile releaseextended releasesustained releasetaste masked releasedelayed release systemsconsisting of selection of drug formulation and delivery systems to optimize performance of active pharmaceutical ingredientsanalytic techniques to test drug formulationsanalytic services to detectidentify and quantify drug componentsstability testingphysical characterizations of formulationsin-vitro release testingall relating to multiple drug product formatssemi-solidssolutionssuspensionsparticulatessolid dispersionssolid solutions and injectables
Publications
History of USPTO decisions and trademark events.
47 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/19/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/19/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/19/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
02/20/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/14/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/14/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/14/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/14/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/14/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/14/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/15/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/06/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/06/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/06/2021
E815
TEAS SECTION 8 & 15 RECEIVED
02/23/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/15/2020
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/14/2020
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/07/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/26/2016
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/26/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
12/15/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/29/2015
PUBO
PUBLISHED FOR OPPOSITION
09/29/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/09/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/26/2015
ALIE
ASSIGNED TO LIE
08/26/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/08/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/07/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/07/2015
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/07/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/01/2015
GNFR
FINAL REFUSAL E-MAILED
07/01/2015
CNFR
FINAL REFUSAL WRITTEN
07/01/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/16/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/15/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/15/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/19/2014
GNRT
NON-FINAL ACTION E-MAILED
12/19/2014
CNRT
NON-FINAL ACTION WRITTEN
12/19/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/15/2014
GNRT
NON-FINAL ACTION E-MAILED
12/15/2014
CNRT
NON-FINAL ACTION WRITTEN
12/15/2014
DOCK
ASSIGNED TO EXAMINER
12/14/2014
MPMK
NOTICE OF PSEUDO MARK E-MAILED
09/13/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/12/2014
NWAP
NEW APPLICATION ENTERED
09/05/2014
Continuous trademark protection
Get notified about every new filing that threatens ORBIS BIOSCIENCES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.